Čes. slov. farm. 2022, 71(2):76-86 | DOI: 10.5817/CSF2022-2-76
Digoxin at sub-cardiotonic dose modulates the anticonvulsive potential of valproate, levetiracetam and topiramate in experimental primary generalized seizures
- 1 Department of Pharmacology and Pharmacotherapy, National University of Pharmacy, Kharkiv, Ukraine
- 2 Department of Neurology, Psychiatry, Narcology and Medical Psychology
- 2 School of Medicine, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine
The prevalence of epilepsy in the world population together with a high percentage of patients resistant to existing antiepileptic drugs (AEDs) stimulates the constant search for new approaches to the treatment of the disease. Previously a significant anticonvulsant potential of cardiac glycoside digoxin has been verified by enhancing a weak activity of AEDs in low doses under screening models of seizures induced by pentylenetetrazole and maximal electroshock. The aim of the present study is to investigate the influence of digoxin at a sub-cardiotonic dose on the anticonvulsant activity of valproate, levetiracetam, and topiramate in models of primary generalized seizures with different neurochemical mechanisms. A total of 264 random-bred male albino mice have been used. AEDs were administered 30 min before seizure induction once intragastrically at conditionally effective (ED50) and sub-effective (1/2 ED50) doses: sodium valproate and topiramate - at doses of 300 and 150 mg/kg; levetiracetam - at doses of 100 and 50 mg/kg. Digoxin was administered once subcutaneously at a dose of 0.8 mg/kg body weight (1/10 LD50) 10-15 min before seizure induction. Picrotoxin (aqueous solution 2.5 mg/kg, subcutaneously), thiosemicarbazide (aqueous solution 25 mg/kg, intraperitoneally), strychnine (aqueous solution 1.2 mg/kg, subcutaneously), camphor (oil solution 1000 mg/kg, intraperitoneally) have been used as convulsive agents for seizure induction. It was found that under the conditions of primary generalized seizures induced by picrotoxin, thiosemicarbazide, strychnine, and camphor, digoxin not only shows its own strong anticonvulsant activity but also significantly enhances the anticonvulsant potential of classical AEDs sodium valproate, levetiracetam, and topiramate. The obtained results substantiate the expediency of further in-depth study of digoxin as an anticonvulsant drug, in particular, the in-depth study of neurochemical mechanisms of its action.
Keywords: digoxin; adjuvant; anticonvulsant; valproate; levetiracetam; topiramate; seizures
Received: January 25, 2022; Accepted: March 30, 2022; Published: February 1, 2022 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Abramovici S., Bagić A. Epidemiology of epilepsy. Handb. Clin. Neurol. 2016; 138, 159-171.
Go to original source...
Go to PubMed...
- Kalilani L., Sun X., Pelgrims B., Noack-Rink M., Villanueva V. The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis. Epilepsia 2018; 59(12), 2179-2193.
Go to original source...
Go to PubMed...
- Pérez-Pérez D., Frías-Soria C. L., Rocha L. Drug-resistant epilepsy: From multiple hypotheses to an integral explanation using preclinical resources. Epilepsy & behavior 2021; 121(Pt B), 106430.
Go to original source...
Go to PubMed...
- Łukawski K., Czuczwar S.J. Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it. Expert opinion on drug metabolism & toxicology 2021; 17(9), 1075-1090.
Go to original source...
Go to PubMed...
- Borowicz K. K., Banach M. Antiarrhythmic drugs and epilepsy. Pharmacol. Reports 2014; 66(4), 545-551.
Go to original source...
Go to PubMed...
- Zeiler F. A., Zeiler K. J., Kazina C. J., Teitelbaum J., Gillman L. M., West M. Lidocaine for status epilepticus in adults. Seizure 2015; 31, 41-48.
Go to original source...
Go to PubMed...
- Łukawski K., Jakubus T., Janowska A., Raszewski G., Czuczwar S. J. Enalapril enhances the anticonvulsant activity of lamotrigine in the test of maximal electroshock. Pharmacol. Reports 2013; 65(4), 1012-1017.
Go to original source...
Go to PubMed...
- Elgarhi R., Shehata M. M., Abdelsameea A. A., Salem A. E. Effects of Diclofenac Versus Meloxicam in Pentylenetetrazol-Kindled Mice. Neurochem. Res. 2020; 45(8), 1913-1919.
Go to original source...
Go to PubMed...
- Suemaru K., Yoshikawa M., Tanaka A., Araki H., Aso H., Watanabe M. Anticonvulsant effects of acetaminophen in mice: Comparison with the effects of nonsteroidal anti-inflammatory drugs. Epilepsy Res. 2018; 140, 22-28.
Go to original source...
Go to PubMed...
- Erdogan M. A., Yusuf D., Christy J., Solmaz V., Erdogan A., Taskiran E., et al. Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy. BMC Neurol. 2018; 18(1), 81.
Go to original source...
Go to PubMed...
- Yimer E. M., Surur A., Wondafrash D. Z., Gebre A. K. The Effect of Metformin in Experimentally Induced Animal Models of Epileptic Seizure. Behav. Neurol. 2019; 2019, 6234758.
Go to original source...
Go to PubMed...
- Quintana-Pájaro L. J., Ramos-Villegas Y., Cortecero-Sabalza E., Joaquim A. F., Agrawal A., Narvaez-Rojas A. R., et al. The Effect of Statins in Epilepsy: A Systematic Review. J. Neurosci. Rural. Pract. 2018; 9(4), 478-486.
Go to original source...
Go to PubMed...
- Scicchitano F., Constanti A., Citraro R., de Sarro G., Russo E. Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions. Curr. Drug Targets 2015; 16(7), 747-756.
Go to original source...
Go to PubMed...
- Shtrygol' S., Shtrygol' D. Digoxin as an antiepileptic in children (clinical and experimental study). Ukrainian Medical Almanac 2010; 13, 164.
- Tsyvunin V., Shtrygol' S., Shtrygol' D. Digoxin enhances the effect of antiepileptic drugs with different mechanism of action in the pentylenetetrazole-induced seizures in mice. Epilepsy Res. 2020; 167, 106465.
Go to original source...
Go to PubMed...
- Tsyvunin V., Shtrygol' S., Shtrygol' D., Mishchenko M., Kapelka I., Taran A. Digoxin potentiates the anticonvulsant effect of carbamazepine and lamotrigine against experimental seizures in mice. Thai J. Pharm. Sciences 2021; 45(3), 165-171.
Go to original source...
- Tsyvunin V., Shtrygol' S., Havrylov I., Shtrygol' D. Low-dose digoxin enhances the anticonvulsive potential of carbamazepine and lamotrigine in chemo-induced seizures with different neurochemical mechanisms. ScienceRise: Pharm. Science 2021; 6(34), 58-65.
Go to original source...
- Duveau V., Pouyatos B., Bressand K., Bouyssières C., Chabrol T., Roche Y., et al. Differential Effects of Antiepileptic Drugs on Focal Seizures in the Intrahippocampal Kainate Mouse Model of Mesial Temporal Lobe Epilepsy. CNS neuroscience & therapeutics 2016; 22(6), 497-406.
Go to original source...
Go to PubMed...
- Markova I. V., Mikhaĭlov I. B., Guzeva V. I. Digoksin-aktivnoe protivoépilepticheskoe sredstvo [Digoxin - an active antiepileptic agent]. Farmakologiia i toksikologiia 1991; 54(5), 52-54.
- Hock F. J. Drug Discovery and Evaluation: Pharmacological Assays. Switzerland: Springer International Publishing 2016.
Go to original source...
- Mironov A. N., Bunyatyan N. D., Vasileva A. N. Guidelines for conducting pre-clinical trials of medicines. Part one. Moscow: Grif and K. 2012.
- Olsen R. W. Picrotoxin-like channel blockers of GAB-AA receptors. Proceedings of the National Academy of Sciences of the United States of America 2006; 103(16), 6081-6082.
Go to original source...
Go to PubMed...
- Santos M. S., Gonçalves P. P., Carvalho A. P. Effect of ouabain on the gamma-[3H]aminobutyric acid uptake and release in the absence of Ca(+)+ and K(+)-depolarization. J. Pharmacol. Exp. Ther. 1990; 253(2), 620-627.
Go to original source...
- Salazar P., Tapia R. Epilepsy and hippocampal neurodegeneration induced by glutamate decarboxylase inhibitors in awake rats. Epilepsy Res. 2015; 116, 27-33.
Go to original source...
Go to PubMed...
- Otter J., D'Orazio J. L. Strychnine Toxicity. In StatPearls. StatPearls Publishing 2021.
- Park T. J., Seo H. K., Kang B. J., Kim K. T. Noncompetitive inhibition by camphor of nicotinic acetylcholine receptors. Biochem. Pharmacol. 2001; 61(7), 787-793.
Go to original source...
Go to PubMed...
- Narayan S., Singh N. Camphor poisoning-An unusual cause of seizure. Medical Journal, Armed Forces India 2012; 68(3), 252-253.
Go to original source...
Go to PubMed...
- Zadvornov А. А., Golomidov А. V., Grigoriev E. V. Clinical pathophysiology of cerebral edema (part 2). Messenger of Anesthesiol. Resus. 2017; 14(4), 52-60.
Go to original source...
- Wei D., Peng J. J., Gao H., Li H., Li D., Tan Y., et al. Digoxin downregulates NDRG1 and VEGF through the inhibition of HIF-1α under hypoxic conditions in human lung adenocarcinoma A549 cells. Int. J. Mol. Sci. 2013; 14(4), 7273-7285.
Go to original source...
Go to PubMed...
- Löscher W. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments. Neuropharmacology 2020; 167, 107605.
Go to original source...
Go to PubMed...
- Perucca E. Antiepileptic drugs: evolution of our knowledge and changes in drug trials. Epileptic disorders: international epilepsy journal with videotape 2019; 21(4), 319-329.
Go to original source...
Go to PubMed...
- Löscher W., Klein P. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond. CNS Drugs 2021; 35(9), 935-963.
Go to original source...
Go to PubMed...
- Waller D., Sampson A. Medical Pharmacology and Therapeutics. 5th ed. U.K.: Elsevier 2017.
- Sills G. J., Rogawski M. A. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology 2020; 168, 107966.
Go to original source...
Go to PubMed...
- Patocka J., Nepovimova E., Wu W., Kuca K. Digoxin: Pharmacology and toxicology-A review. Environmental toxicology and pharmacology 2020; 79, 103400.
Go to original source...
Go to PubMed...
- de Lores Arnaiz G. R., Ordieres M. G. Brain Na(+), K(+)-ATPase Activity In Aging and Disease. Int. J. Biomed. Sci. 2014; 10(2), 85-102.
Go to original source...
- Funck V. R., Ribeiro L. R., Pereira L. M., de Oliveira C. V., Grigoletto J., Della-Pace I. D., et al. Contrasting effects of Na+, K+-ATPase activation on seizure activity in acute versus chronic models. Neuroscience 2015; 298, 171-179.
Go to original source...
Go to PubMed...
- Krishnan G. P., Filatov G., Shilnikov A., Bazhenov M. Electrogenic properties of the Na +/K+ ATPase control transitions between normal and pathological brain states. J. Neurophysiol. 2015; 113(9), 3356-3374.
Go to original source...
Go to PubMed...